Nine Collaborations Underway, Company Aligns to Accelerate Business
Development in Health, Food, Energy and Environment
GERMANTOWN, Md., May 9, 2013 /CNW/ - Intrexon Corporation, a leader in
synthetic biology that is helping companies design and develop products
incorporating its Better DNA™, today announced it has aligned its industry
markets to focus on four key sectors: Health, Food, Energy and Environment.
Intrexon currently has nine collaborations in Health and Food to create
products embodying engineered bio-based solutions. The goal of the new market
alignment is to accelerate business development across all of Intrexon's key
market sectors using the company's Exclusive Channel Collaboration (ECC) model.
Since Intrexon's founding in 1998 the company has developed its core
technology, the UltraVector® platform, to accelerate development of
genetically-enhanced products at industrial scale. Using a dynamic library of
more than two million diverse, modular genetic components, UltraVector enables
the discovery, design, assembly and testing of a wide spectrum of multigenic
As part of its new market strategy, Intrexon named the following executives
with deep industry experience to lead each market sector:
-- Health will be led by Dr. Samuel Broder, Executive Director of
the Intrexon Institute for Biomolecular Research and former
Director of the National Cancer Institute.
-- Food will be led by Dr. Thomas Kasser, with more than
twenty-five years of senior management experience in
agricultural biotechnology and animal health and nutrition,
recognized as a Monsanto Fellow for his scientific and
-- Energy will be led by Robert Walsh, with over 30 years of
global petroleum and chemical industry experience, including 26
years at Royal Dutch Shell.
-- Environment will be led by Nick Macris, with 15 years in the
specialty chemical, water treatment, agricultural chemical and
biopesticide industries with many large and small companies
including 3M, Rohm and Haas, and FMC Corporation
Chairman and Chief Executive Officer Randal J. Kirk said the new market
alignment will help Intrexon achieve its vision to be one of the leading life
science companies in the world.
"Our new sector organization, led by an outstanding team of industry veterans,
will bring additional focus and rapidity to solving our partners' toughest
synthetic biology problems," Kirk said. "It's a very exciting step toward
empowering the bioindustrial revolution with solutions that enhance the
quality and diversity of life."
About Intrexon Corporation
Intrexon Corporation is a privately held biotechnology company focused on
collaborating with companies in Health, Food, Energy and the Environment to
create bio-based products that improve the quality of life and the health of
the planet. Through the company's proprietary UltraVector® platform,
Intrexon provides its partners with industrial-scale design and development of
multigenic biology. UltraVector delivers unprecedented control over the
quality, reliability, and performance of living cells. We call it Better
DNA™ and we invite you to discover more at www.dna.com.
Intrexon, UltraVector, mAbLogix and Better DNA are trademarks of Intrexon
and/or its affiliates. Other names may be trademarks of their respective
Safe Harbor Statement
Some of the statements made in this press release are forward-looking
statements. These forward-looking statements are based upon our current
expectations and projections about future events and generally relate to our
plans, objectives and expectations for the development of our business.
Although management believes that the plans and objectives reflected in or
suggested by these forward-looking statements are reasonable, all
forward-looking statements involve risks and uncertainties and actual future
results may be materially different from the plans, objectives and
expectations expressed in this press release.
For more information regarding Intrexon Corporation, contact:
Corporate Contact: Investor Contact:
Marie L. Rossi, Ph.D. The Ruth Group
Manager, Technical Communications Stephanie Carrington /
Intrexon Corporation Tel: +1 646-536-
Tel: +1 301-556-9944
SOURCE: Intrexon Corporation
To view this news release in HTML formatting, please use the following URL:
CO: Intrexon Corporation
NI: HEA MTC BTC
-0- May/09/2013 18:39 GMT
Press spacebar to pause and continue. Press esc to stop.